ArticleDiscover oncology2024
Predicting prostate adenocarcinoma patients' survival and immune signature: a novel risk model based on telomere-related genes.
Jiefang Zheng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it